01OverviewDefinition, clinical context and the essential points that orientate the chapter.
Eyelid malignancy includes tumours of skin, glands and other periocular tissues. Basal cell carcinoma is the most common type in the UK setting; squamous cell carcinoma, sebaceous carcinoma and melanoma are less frequent but clinically important. The eyelid is a specialised functional structure, not simply a convenient site for removal of a skin blemish. Its margin, lashes, tear drainage and close relationship to the cornea mean that even a small lesion can require careful planning.
Basal cell carcinoma often appears as a slowly enlarging painless nodule or a non-healing ulcer with a raised edge and fine surface vessels. Some lesions are pigmented or have less obvious infiltrative borders. Metastasis is exceptionally uncommon, but unchecked local invasion can damage the lid, medial canthus, drainage apparatus or orbit. Its usually slow pace should therefore inform the referral decision without creating a blanket assumption that delay is harmless around the eye.
Squamous cell carcinoma may present as a keratinising, crusted or ulcerated lesion and can grow more quickly. It has a greater capacity for regional and distant spread than basal cell carcinoma. Sebaceous carcinoma may instead resemble a firm tarsal nodule, a recurrent chalazion or persistent one-sided lid and conjunctival inflammation. Tumour spread within the surface epithelium can extend beyond the obvious lump. These presentations explain why repeated treatment of a presumed benign lesion should prompt reconsideration when its behaviour or architecture becomes atypical.
Melanoma can be irregularly pigmented, changing or bleeding, but lack of pigment does not exclude it. Nodular melanoma may be pink or otherwise non-pigmented. The standard skin-cancer assessment considers evolution and suspicious clinical features rather than relying solely on colour. The clinician should describe the lesion accurately and refer when concern is justified; attempting to name the exact histological type before referral is less important than recognising that the finding needs specialist assessment.
Ask how the lesion began, whether it has grown, whether it bleeds spontaneously and what previous procedures or treatments have been tried. Record immunosuppression, previous skin cancer, radiotherapy and relevant sun exposure. Examine the lid margin and the surrounding skin, noting lash loss, ulceration, fixation and altered position. Where appropriate and within competence, assess the conjunctival surface and regional lymph nodes. Document vision and corneal protection when the lesion disrupts closure, and ask specifically about numbness, diplopia or displacement of the eye.
Referral follows the local skin-cancer and oculoplastic arrangements. NICE recommends suspected-cancer pathways for suspicious melanoma and consideration of that pathway for suspected squamous cell carcinoma. Basal cell carcinoma is usually referred non-urgently, but suspected-cancer referral is appropriate when site or size means delay could have a substantial impact. A growing medial-canthal lesion or one damaging lid function may meet that concern. Suspected sebaceous malignancy needs prompt specialist discussion. Provide the features supporting urgency rather than relying on the label 'eyelid lump'.
Biopsy establishes tumour type and helps plan treatment, although an appropriate specialist may combine diagnosis with complete removal for selected lesions. The specimen must be accurately labelled, with site, prior procedures and the suspected diagnosis communicated to pathology. Margin-controlled excision, including Mohs surgery when appropriate, can remove tumour while conserving uninvolved tissue. Reconstruction then restores closure, support and a tolerable surface environment. Larger defects do not all require the same operation, and the pathology result can change the reconstructive plan.
Follow-up is individualised according to tumour type, histology, margins, recurrence risk and treatment. It includes both cancer surveillance and functional recovery. The patient needs to know who will explain the histology, whether further treatment is required and how to seek help for a new lesion or change near the scar. Sun protection and self-awareness remain useful after successful treatment, while support for altered appearance, anxiety and visual difficulties should be offered without assuming that a technically successful excision resolves every concern.
Key points
- Basal cell carcinoma is common and can be locally destructive.
- Squamous and sebaceous carcinomas can spread beyond the primary site.
- A recurrent chalazion can occasionally conceal sebaceous malignancy.
- Lash loss and disrupted architecture deserve specific documentation.
- A small eyelid tumour can still threaten important structures.
- Referral urgency depends on tumour suspicion, site and likely impact.
- Tissue clearance and preservation of eyelid function both matter.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Ultraviolet and host risk
Accumulated ultraviolet exposure contributes to many eyelid skin cancers, while immune suppression increases susceptibility. Age, prior skin malignancy and inherited predisposition influence risk without determining the diagnosis of an individual lesion.
Different cells of origin
Basal and squamous carcinomas arise from epithelial lineages, sebaceous carcinoma from sebaceous differentiation and melanoma from melanocytes. These biological differences account for varied appearances and patterns of local or distant spread.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Local tissue destruction
Tumour growth can replace normal lid structures and disrupt the lash line, margin and supporting tissues. Functional changes may include poor apposition, drainage disturbance and inadequate corneal protection.
- 2Pagetoid epithelial spread
Sebaceous carcinoma can spread within the surface epithelium beyond the main tumour. This pattern may produce diffuse irritation or inflammation and make the clinically visible lump an incomplete representation of disease extent.
- 3Invasion and dissemination
Some eyelid cancers extend along tissue planes or nerves and can involve regional lymph nodes or distant sites. Basal cell carcinoma predominantly causes local damage, while other histologies have greater metastatic potential.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Look for a persistent pearly or waxy nodule, surface vessels, ulceration or an indistinct scar-like lesion. Record medial-canthal involvement and any effect on the lid margin or drainage structures.
Increasing size, keratin, crusting, recurrent bleeding and tissue distortion raise concern for malignancy. A painless lesion may still be invasive and does not merit dismissal on that basis.
A nodule recurring at one site, focal lash loss or resistant unilateral blepharoconjunctivitis should trigger reconsideration of sebaceous carcinoma, especially when the clinical course differs from usual gland obstruction.
Describe change, asymmetry, colour variation and surface features, while remembering that nodular melanoma can lack obvious pigment. Dermoscopy is useful when performed and interpreted by an appropriately trained clinician.
Check altered sensation, fixation, nodes, ocular movement and globe position when relevant. These findings can affect staging and urgency even when the visible skin component seems small.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Clinical measurements and photographsFirst step - Why
- Document morphology and provide useful information for specialist triage.
- Interpretation and limitations
- Record exact site, size, progression and effect on lid function; photographs with appropriate consent support comparison but do not replace direct assessment or tissue diagnosis.
- 02
Specialist biopsy and histology - Why
- Determine tumour type and features relevant to definitive treatment.
- Interpretation and limitations
- Incisional or excisional sampling depends on the lesion and planned surgery; an atypical recurrent lesion should be clearly identified to pathology rather than submitted with an unsupported benign label.
- 03
Margin assessment - Why
- Determine whether removal has achieved adequate tumour clearance.
- Interpretation and limitations
- The technique may involve permanent sections or a specialised margin-controlled approach; the final report influences re-excision, reconstruction and follow-up.
- 04
Conjunctival assessment in suspected sebaceous disease - Why
- Look for disease extending beyond the obvious lid nodule.
- Interpretation and limitations
- The specialist may plan targeted or mapping biopsies when indicated; surface involvement and a nondiagnostic specimen need interpretation by the experienced clinical-pathology team.
- 05
Imaging and regional or systemic staging - Why
- Assess suspected extension or dissemination when tumour features justify it.
- Interpretation and limitations
- Orbital imaging and nodal investigations are selected by the relevant team; routine whole-body staging is not necessary for every small basal cell carcinoma.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Chalazion and gland inflammation
A chalazion produces a firm tarsal nodule through gland obstruction and inflammation. Persistent recurrence at one location with architectural destruction is less typical of an uncomplicated benign gland lesion.
Benign skin lesions
Papillomas, cysts and other benign growths can form eyelid lumps with irritation or secondary inflammation. Stability and preserved normal structures may support benignity, although appearance alone does not resolve every uncertain lesion.
Inflammatory lid disease
Blepharitis, contact dermatitis and related surface inflammation can cause redness and irritation. Resistant unilateral disease or focal destructive change is less consistent with ordinary diffuse lid inflammation.
Premalignant or in-situ disease
Actinic keratosis, squamous carcinoma in situ and lentigo maligna may produce persistent surface abnormalities. Their biological extent differs from invasive cancer, but clinical overlap can make distinction difficult.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Suspicious lesionRefer with a clear risk descriptionFirst stepAn eyelid lesion has concerning morphology, evolution or recurrent behaviour.+
- 1Record growth, bleeding, lash loss, previous treatment and any functional effect.
- 2Use the local suspected-cancer or specialist referral route appropriate to the suspected tumour.
- 3Discuss urgency directly when site, size or diagnostic uncertainty creates concern about delay.
- 4Explain that referral investigates a possibility and does not itself confirm cancer.
02Unusual recurrent inflammationReconsider a presumed benign diagnosisA recurring lid nodule or unilateral inflammation fails expected management.+
- 1Review whether earlier lesions were at the same location and whether tissue was examined.
- 2Look for lash loss, tarsal thickening and conjunctival involvement.
- 3Arrange prompt oculoplastic or eyelid-oncology assessment for possible sebaceous malignancy.
- 4Avoid further destructive treatment that could compromise diagnosis without an agreed tissue plan.
03Confirmed malignancyCoordinate clearance and reconstructionHistology or specialist assessment establishes a tumour requiring treatment.+
- 1Discuss the diagnosis and any additional staging with the appropriate multidisciplinary team.
- 2Agree excision or another tumour-specific treatment according to type, extent and patient priorities.
- 3DefinitiveConfirm the margin-management plan before definitive reconstruction where clinically appropriate.
- 4Arrange a named results and follow-up pathway covering recurrence and eyelid function.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Exposure and drainage dysfunction
Lid-margin destruction or malposition can expose the cornea and impair tear drainage. The resulting discomfort, watering or surface damage may be the first functional consequence of a growing lesion.
Orbital or neural extension
Deep tumour growth can involve the orbit or nearby nerves, producing fixation, sensory changes, diplopia or globe displacement. Such extension increases the complexity and potential morbidity of the disease.
Recurrence and metastatic disease
Residual or recurrent tumour may develop near the original site, sometimes after a prolonged interval. The likelihood of regional or distant spread varies with histology and other tumour characteristics.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- Track the biopsy result and any recommended re-excision to completion; assign responsibility for communicating the result and arranging the next step.
- Follow-up frequency and duration should reflect histology, margin status and recurrence risk, with examination of the scar, adjacent surfaces and relevant lymph nodes where indicated.
- Assess closure, lid position, tear drainage and corneal comfort after reconstruction; persistent exposure or visual change needs ophthalmic reassessment.
- Advise the patient to report a growing scar-edge lump, new ulceration, recurrent bleeding, lash loss or renewed unilateral inflammation without waiting for the next scheduled visit.
- Review prevention and support needs, including sensible sun protection, awareness of other skin lesions and practical help with altered appearance or vision.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
The hidden component matters
The visible skin lesion may underestimate involvement of the lid margin, inner surface or neighbouring structures. A careful description of functional change can therefore be as useful as the diameter measured on a photograph.
Margin control preserves tissue
Mohs surgery examines removed layers and directs further removal towards remaining tumour. Its value near the eye includes conserving uninvolved tissue, although the choice of technique still depends on tumour type and local expertise.
Histology needs clinical context
Tell the pathologist about recurrence, prior treatment and suspected sebaceous disease. Current ophthalmic pathology advice should determine the preparation; do not assume every unusual lesion needs an improvised fresh or unfixed sample.
Low metastatic risk is not zero morbidity
Basal cell carcinoma can cause substantial local destruction even though distant spread is exceptionally rare. Explaining this distinction helps a patient understand the benefit of timely treatment without overstating systemic cancer risk.
11Common pitfallsFrequent interpretation and management errors.
- 01
Repeating chalazion treatment despite recurrence at one site and loss of normal lashes.
- 02
Treating every suspected basal cell carcinoma as equally urgent or equally safe to delay.
- 03
Excluding melanoma because a growing nodule is not darkly pigmented.
- 04
Removing a suspicious lid-margin lesion without an appropriate specialist and pathology plan.
- 05
Assuming successful reconstruction proves that histological clearance has been achieved.